CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate‐Induced Excitotoxicity Through a Reduction of NOX ‐2 Activity and Oxidative Stress
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.70099 ↗At a glance
Journal article in CNS Neuroscience & Therapeutics, 2024. Written by Ari Misael Martínez-Torres and 1 co-authors. Institution: División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México, Mexico. Major MEDLINE topics: Oxidative Stress, NADPH Oxidase 2, Mice, Inbred C57BL, Benzoxazines. Cited 15 times so far (Crossref); 76 references. The full text is freely available (open access, CC BY 4.0). Funded by: Consejo Nacional de Humanidades, Ciencias y Tecnologías, Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México, Consejo Nacional de Ciencia y Tecnología.
Abstract (original language)
Background
Excitotoxicity is a process in which NADPH oxidase‐2 (NOX‐2) plays a pivotal role in the generation of reactive oxygen species (ROS). Oxidative stress influences the expression of Aquaporin 4 (AQP4), a water channel implicated in blood–brain barrier (BBB) permeability and edema formation. The endocannabinoid system is widely distributed in the brain, particularly through the cannabinoid receptor type 1 (CB1) and type 2 (CB2), which have been shown to have a neuroprotective function in brain injury. Given the significant involvement of NOX‐2 in ROS production during excitotoxicity, our research aims to assess the participation of NOX‐2 in the neuroprotective effect of the cannabinoid receptor agonist WIN55,212‐2 against glutamate‐induced excitotoxicity damage in the striatum using in vivo model.
Methods
Wild‐type mice (C57BL/6) and NOX‐2 KO (gp91 Cybbtm1Din/J ) were stereotactically injected in the striatum with monosodium glutamate or vehicle. Subsequently, a group of mice was administered an intraperitoneal dose of WIN55,212‐2, AM251, or AM251/WIN55,212‐2 following the intracerebral injection. Motor activity was assessed, and the lesion was examined through histological sections stained with cresyl violet. Additionally, brain water content and Evans blue assay were conducted. The activity of NOX was quantified, and the protein expression of CB1, gp91 phox , AQP4, Iba‐1, TNF‐α, and NF‐κB was analyzed using Western blot. Furthermore, ROS formation was measured through the DHE assay.
Results
The activation of the endocannabinoid receptors demonstrated a neuroprotective response during excitotoxicity, meditated by NOX‐2. The reduction in ROS production led to a decrease in neuroinflammation, and AQP4 expression, resulting in reduced edema formation, and BBB permeability.
Conclusions
During excitotoxic damage, WIN55,212‐2 inhibits NOX‐2‐induced ROS production, reducing brain injury.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- División de Neurociencias, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
ORCID profiles: Julio Morán
Funding
- Consejo Nacional de Humanidades, Ciencias y Tecnologías
- Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México
- Consejo Nacional de Ciencia y Tecnología
Cite
APA
Martínez-Torres, A. M., & Morán, J. (2024). CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate‐Induced Excitotoxicity Through a Reduction of NOX ‐2 Activity and Oxidative Stress. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70099
Vancouver
Martínez-Torres AM, Morán J. CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate‐Induced Excitotoxicity Through a Reduction of NOX ‐2 Activity and Oxidative Stress. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.70099
BibTeX
@article{MartnezTorres2024,
author = {Martínez-Torres, Ari Misael and Morán, Julio},
title = {CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate‐Induced Excitotoxicity Through a Reduction of NOX ‐2 Activity and Oxidative Stress},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.70099}
}
EUVIMED